Why the study?
Alignment between clinician-reported NYHA class and patient-reported outcomes among patients hospitalized for heart failure is unclear.
What is the degree of discordance between clinician-reported NYHA class and patient-reported health status in patients hospitalized for heart failure, and is this discordance associated with clinical outcomes?
What is the degree of discordance between clinician-reported NYHA class and patient-reported health status in patients hospitalized for heart failure, and is this discordance associated with clinical outcomes?
There is significant discordance between clinician-assessed NYHA class and patient-reported health status in hospitalized heart failure patients, and patients who perceive their health as worse than their clinicians do face a higher risk of mortality.
Answers are grounded in this paper and cite their sources.
Discordance between NYHA class and patient-reported outcomes is common in hospitalized HF; challenges sole reliance on clinician assessment and supports PRO inclusion in trials.
Background: Alignment between clinician-reported New York Heart Association (NYHA) class compared and patient-reported outcomes among patients hospitalized for heart failure is unclear. Methods: ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) was a global randomized trial comparing nesiritide versus placebo among patients hospitalized for heart failure, irrespective of ejection fraction. Among patients with complete baseline data for NYHA class and the patient-reported EuroQOL-5 dimensions ([EQ-5D], both utility index and visual analog scale), levels of each scale were mapped across 4 prespecified categories “best” to “worst.” Minor and moderate-severe discordance were defined as NYHA class and EQ-5D differing by 1 level and ≥2 levels, respectively. Multivariable models assessed factors independently associated with moderate-severe discordance, and associations between discordance and clinical outcomes. Results: Among 5741 patients, concordance, minor discordance, and moderate-severe discordance between NYHA class and EQ-5D utility index occurred in 22%, 40%, and 38% of patients, respectively. For NYHA class and EQ-5D visual analog scale, this categorization occurred in 29%, 48%, and 23%. Discordance was more often due to disproportionately higher EQ-5D score (78% of discordance cases with utility index, and 70% with visual analog scale). NYHA class IV, higher EQ-5D scores, race, and geographic region were among patient factors independently associated with moderate-severe discordance. Magnitude of discordance was not associated with clinical outcomes; however, EQ-5D utility index disproportionately worse than NYHA class was associated with increased 180-day mortality (adjusted hazard ratio 1.27 [95% CI, 1.01–1.60]; P =0.04). Conclusions: In a global trial cohort of patients hospitalized for heart failure, the majority of patients exhibited discordance between clinician-reported NYHA class and patient-reported health status. Multiple patient factors were independently associated with moderate-severe discordance, and patients who perceived their health status as worse than the clinician’s perception had higher mortality. Registration: URL: http://www.clinicaltrials.gov ; Unique identifier: NCT00475852.
No takes yet. Share an insight, caveat, or question.
Cosiano et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: